Navigation Links
Polyunsaturated Fat, Vitamin E Lowers Risk Of Motor Neurone Disease

Risk of developing motor neurone disease can be reduced by around 60 percent, by using a diet, which is high in polyunsaturated fat// or vitamin E, according to a new study.

In the study, polyunsaturated fat included both omega-6 fat found abundantly in vegetable oils such as corn oil and omega 3 fat found in fish and nuts, reports foodconsumer.org.

The motor neurone diseases (MND) are a group of progressive neurological disorders that destroy motor neurons, the cells that control voluntary muscle activity such as speaking, walking, breathing, and swallowing.

In the study, researchers compared 132 patients with potential or definite amyotrophic lateral sclerosis (ALS) with 220 healthy people with a similar background, including age, sex, energy intake, weight, and smoking habit, for their dietary habits. Participants were surveyed through a questionnaire, detailing their regular intake of a variety of nutrients including polyunsaturated fats (PUFAS), vitamin E, flavonols, calcium, lycopene and others. Researchers found the patients with ALS consumed significantly lower amounts of PUFAS and vitamin E than the control group did while the total energy intake and consumption of dietary supplements were the same in both groups. Specifically, those who consumed more than 32 grams of PUFAS daily were 60 percent less likely to develop ALS compared with those who took less than 25 grams, the study found. Taking 18 to 22 mg of vitamin E daily reduced the risk of ALS by 60 percent compared with those who took 18 grams or less. In addition, vitamin E and polyunsaturated fat seemed to work synergistically to reduce the ALS risk. The association between PUFAS/vitamin E and the risk was still significant even after other risk factors were considered. There was no association found between other nutrients and the ALS risk Still, the study was not meat to establish a causal relation between polyunsaturated fat/vitamin E intake and the risk of motor neurone disease. High intake of PUFAS and vitamin E may probably, but not definitely have an effect on the risk of ALS. More studies are needed to confirm the observation.
'"/>




Related medicine news :

1. Polyunsaturated Fats And Vitamin E Cut MND Risk By 60 Percent
2. Vitamin B12 can help in detecting cancers
3. Vitamins-The answer to Heart Disease?
4. Vitamin E, the latest warrior against diabetes
5. Vitamin Shields Brittle Bones
6. B Vitamin protects and lowers toxicity of Arthritis Drug
7. B Vitamin Supplementatoin Saves Money and Lives
8. Eat Vitamin C and stay young
9. Vitamin C for the heart
10. Vitamin B for Hepatitis
11. Vitamins reduce pre-eclampsia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... , ... Five consumer packaged goods (CPG) products were selected by the SupplySide ... Nopavera Plus was named to the short list in the Specialty Supplements category. ... presentations at SupplySide Central on Sept. 27 and 28 at Mandalay Bay Resort in ...
(Date:9/20/2017)... ... 2017 , ... “The Trials I Face to Receive God’s Grace”: a ... aspirations and goals to better one’s life through God. “The Trials I Face to ... all the wrong places, found a love for writing. Green feels that expressing his ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Psalms of Humidity”: is ... of mind and move the readers one step closer to God. “Psalms of Humidity” ... that his mistakes that have been made within his life are the very same ...
(Date:9/19/2017)... ... September 19, 2017 , ... With a series of ... more than $15,000 in just a couple of weeks for those affected by ... world-class instructor seminars, organizers expect to double those initial funds with the “Submit ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... Compliance and Safety for the President’s Malaria Initiative (PMI) Africa Indoor Residual ... Innovation to Action Award. , The Innovation to Action Award, a USAID ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
(Date:8/29/2017)... 2017 ivWatch, LLC, the leading provider of continuous monitoring ... has been awarded an Innovative Technology contract from Vizient, Inc., the ... ... in the early detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ...
Breaking Medicine Technology: